Login     Register  
    Home  |   Your Profile  |   Search  |   About Us  |   Disclaimer  |   Pricing  |   Participating on CanBiotech
Can Biotech - BioPharma Portal and B2B Marketplace Pre-Filled Syringes East Coast
Site Search:
    Home Open Innovation Engaged Thinking Patient Engagement Events News Careers Directory
 Innovation Blogs   Show all: Innovation Blogs

Singapore QuickFire Challenge - Metabolic Disease Innovation
The QuickFire Challenge will award the entrepreneur, academic, and biotech researchers who submit the best ideas, technologies, or solutions holding the potential of making a major difference to the millions of people in Asia Pacific and around the world who suffer from metabolic diseases such as diabetes and obesity. Winners will be awarded with SGD100,000 project money, access to ETPL laboratory space and one year of mentorship and coaching by Johnson & Johnson Innovation, ETPL and SMART staff.

The initiative underscores Johnson & Johnson’s strong commitment to working in partnership to nurture the healthcare ecosystem in global innovation hotspots around the world, like Singapore, with the aim of positively impacting human health through innovation. The Challenge demonstrates Johnson & Johnson Innovation’s unique vision for collaboration in an open innovation model, aiming to combine Johnson & Johnson Innovation’s global reach and expertise with Singapore’s unique capabilities in innovation to identify breakthrough solutions for the diagnosis and/or treatment of metabolic diseases.
Read More...

Capturing the Value of Patient Engagement: Summary of Results of the Study of Patient-Centric Initiatives in Drug Development
Read this executive summary and detailed study results that include key insights in the following areas: adoption of patient-centric initiatives by pharmaceutical and biotech companies, barriers to adoption of patient-centric initiatives, comparative analytics and results of patient-centric initiatives.
Read More...

The Evolution of Patient Engagement at FDA
Although advancements in incorporating the patient voice have been made over the past few decades, there are still patients who feel frustrated with the rate of progress.
Read More...

Will GSK’s new ‘ethical’ approach to its customers deliver commercial success?
This is the question eyeforpharma answers in its latest whitepaper on GSK's radical new customer engagement model. Read the full paper here
https://goo.gl/w0H9k7

Lessons for Patient Driven Innovation: Rebuild Personas According to Your Next Product Innovation
By exclusively focusing on your persona’s one main need and trying hard to fulfill that need with your product, you can build the next feature with a more focused vision.
Read More...

Culture and Process Change for Patient Engagement
Patient Focused Medicines Development (PFMD) is a not-for-profit independent multinational coalition of patients, patient stakeholders, and the pharmaceutical industry with interests across diverse disease areas and conditions.
Read More...

Lessons on Design Thinking from P&G and Pfizer
Learn more on the how, and why, both P&G and Pfizer view design thinking as a tool set that helps individuals and companies problem-solve.
Read More...

Opening the Door to Patients
The Open House concept was born towards the end of 2014 when Janssen was approached by a large patient group in the oncology space. The group asked if the company would be interested in supporting them in work that they felt would contribute towards improving patient outcomes. As discussions progressed, it became clear that a new model of interaction might be appropriate.
Read More...

It takes two to tango: how shared decision making can help patients and providers make better decisions together
Shared Decision Making
Thursday, September 15, 2016 at 1 PM in Paul Brest Hall, Stanford University.
You make decisions every day. Some are good; some are not as good. Did you know there is a science to decision making that can help people make better decisions more often? In collaboration with Eli Lilly, Medicine X will facilitate a half-day design workshop about improving decision making for patients and providers.
Read More...

Do Patents Promote or Hinder Innovation
A petition recently filed with the Supreme Court triggers renewed debate about the role of patents in the diagnostics sector.
Read More...

Innovation Communities
The Communities of Practice concept is a key lever for innovation, but often overlooked. The best innovation programs leverage CoPs to support continuous innovation across an organization.
Read More...

WEBINAR: How Pfizer Built a Global Innovator Network
Pfizer's Daniel Seewald explores the keys to success in creating a global network of innovation “champions” over scarcely more than two years.
Read More...

Using the Internet to Raise Disease Awareness
The continued rise of social media and the various fundraiser pages can be great for any disease awareness campaign. Patients who have the diseases that are being campaigned for are more likely to engage via social media than the other campaign methods.
Read More...

Strategies for Patient Engagement
Positive and credible engagement of patients is critical for completion of clinical trials and to achieve business results. The CLEAR method leverages: credibility, literacy, expectation management, accessibility and that relates to patients.
Read More...
Precision Medicine Intiative
Precision Medicine is an innovative approach that takes into account individual differences in people’s genes, environments, and lifestyles.
Read More...

Patient Engagement Practices in Clinical Research among Patient Groups, Industry, and Academia in the United States: A Survey
This study aims to gain a better understanding of attitudes and practices for engaging patient groups.

Partnership between Pharma and Patients

Jane Griffiths, Company Group Chairman, Janssen EMEA discusses the relationship between industry and patients.
Read More...

Learning more from Patients Regarding Engagement
What can learn pharma from patients regarding engagement expectations including data collection, communication and the usage of technology.
Read More...

A Focus on People, Ideas and Culture: Bayers Model of Innovation
Bayer's model of innovation is a holistic model for people and their ideas. The model assists with the creation, nurturing, and enhancing of people and ideas.

Engaging patients for drug repurposing: Mapping the patient engagement continuum
November 2015
The chance exists to engage patients directly through crowd research and patient journey mapping as well as indirectly through patient health information to seek new opportunities for drug repurposing. Case examples are used in this article to shed light on programs that have been initiated by a variety of stakeholders including patients themselves to elucidate drugs that potentially are candidates for drug repurposing.

Patient Research Priorities
October 2015
Is there a disparity between what patients think are research priorities and the focus of academic/industry studies? Patients become experts in regard to disease and health management; their research priorities can often differ from those of academic/industry based researchers.
Read More...

Patient Engagement/Engaged Thinking Social Community Launched
September 18 2015
Visit CanBiotech's new patient engagement and engaged thinking community. Participate in the development of the concept of engaged thinking in health innovation and the identification of "lead patients".
Read More...

Listening to Patients
September 2015

In its own move to patient centricity, Sanofi seeks to use practical cases internally to illustrate to staff how things can change toward patient centricity.
Read More...

Continuing Reading More Innovation News and Blogs...


 Innovation Blogs   Show all: Innovation Blogs

Fostering Behavior Change for Better Health

Using design thinking, researchers developed five distinct patient segments and created journey maps to chart the experiences of patients from each of these segments from diagnosis to long-term treatment adherence in the context of HIV management.
Read More...

Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes
September 2015

The collaboration will pair Sanofi’s leadership in diabetes treatments and devices with Google’s expertise in analytics, miniaturized electronics and low power chip design. The companies will explore how to improve diabetes care by developing new tools that bring together many of the previously siloed pieces of diabetes management and enable new kinds of interventions. This includes health indicators such as blood glucose and hemoglobin A1c levels, patient-reported information, medication regimens and sensor devices.

Read More...

The Lilly COI API and TrialReach: A Story of Innovation
August 2015

A vision for inclusive and participatory clinical knowledge generation, with particpation by all including patients in the clinical research ecosystem. Participatory is at the core of open innovation at Lilly.
Read More...

Patient Engagement and Cultural Competence
July 2015

Should the pharmaceutical industry consider cultural competence a driver for more holistic patient engagement? Care providers and health care organizations are seeking to align patient engagement and cultural competency to better understand disease management and compliance issues.
Read More...

Pfizer's Global Innovation Network
June 2015

In this webinar, Pfizer's Daniel Seewald explores the keys to success in creating a global network of innovation “champions”.
Read More...

An Interview with Novartis
June 2015

In this interview, the CEO of Swiss pharmaceutical company Novartis, Joseph Jimenez, discusses how digitization is driving innovation, and why Novartis is shifting to an outcomes-based approach for patient treatments.
Read More...


Pharma Behind Other Industries in Customer Engagement

Expanded Patient Role
June 2015

Patient engagement can be traced across the drug-development pipeline including the impact of recent policy initiatives, and prospects moving forward.
Read More...


Exploring open innovation with a patient focus in drug discovery: an evolving paradigm of patient engagement
It is suggested in this article that patient engagement should occur further upstream during the drug discovery stage. ‘Lead patients’, namely those patients who are proactive with respect to their health, possess knowledge of their disease and resulting symptoms. They are also well informed about the conventional as well as non-conventional treatments for disease management; and so can provide a nuanced perspective to drug design.
Read More:
http://informahealthcare.com/doi/abs/10.1517/17460441.2015.1037271

Healthier Mothers, Healthier Children: Breaking the Cycle of Poverty
April 2015

A Patient Engagement Framework: Leveraging E-Health Tools
April 2015

The HIMSS patient engagement framework outlines patient engagement strategies that leverage eHealth tools and resources to transform patients into partners rather than isolated consumers.
Read More...

Partnering for Health-Patients, Pharma and Clinical Trials

Patients, Prevention and Partnerships
March 2015

New AMA, CDC Initiative Aims to "Prevent Diabetes STAT"
CHICAGO, Thursday, March 12, 11:24 AM
With more than 86 million Americans living with prediabetes and nearly 90 percent of them ...

First independent U.S. psoriasis registry will track drug safety and effectiveness
PORTLAND, Ore., Thursday, February 26, 8:18 AM
People with psoriasis and their health care providers will have the opportunity to participate in...

Health, Prevention and Collaboration
Collaboration between the public health and health-care sectors will enable for the better use of prevention and early detection services. This collaborative approach seeks to build communities that encourage health first rather than disease management only.
Read More...

Co-Creating with Employees and Patients
March 2015

Empathy, patient-centricity and co-creation are re-shaping both drug development and clinical trials at Roche.
Read more..


Klaus Griesar, Merck KGaA: Tips for Breakthrough Innovation in the Pharmaceutical Industry
Source: ISPIM, 2014

Open Innovation: Creating a Network of Programs and Tools at Siemens
March 2015

TechnoWeb is an internal social media tool allowing Siemens to network more than 35,000 experts within approximately 1,200 technology-oriented communities. It is an open platform; every Siemens employee can open a new network or join existing ones.
Read More...

Building the Patient Centric Organization
February 2015

Successfully adopting the patient centric perspective proves to be a challenge for biopharmaceutical organizations.
Read More...

Patient Centricity: Pfizer's Engagement with Patients
January 2015

To better enable patient engagement across the drug discovery and development value chain, the company has become more systematic, progressing beyond the simple engagement of patients in clinical trials.
Read More...

Design for Health
January 2015

Explore principles of design-thinking and patient-centered design, and examine their impact on innovating solutions to healthcare problems.
Read More...


Using the Site Privacy & Security Statement Advertise with us Directory Guide & Access Policy Event Postings CanBiotech Newsletters

© 2000-2017 CanBiotech™ Inc.